Opus Genetics Inc
For the period ended Sep 30, 2024. Filed Nov 12, 2024.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Sep 30, 2024 · Filed Nov 12, 2024
IRD$4.20+0.5%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 6. Exhibits
| Item 6. | Exhibits |
|---|
| EXHIBIT | |
|---|---|
| NUMBER | DESCRIPTION OF DOCUMENT |
| 2.1 | Agreement and Plan of Merger, dated as of October 22, 2024, by and among the Company, Former Opus, Orange Merger Sub I, Inc., and Orange Merger Sub II, LLC (incorporated by reference to Exhibit 2.1 to Registrant’s Current Report on Form 8-K, filed on October 22, 2024). |
| 3.1 | Certificate of Designation of Series A Non-Voting Convertible Preferred Stock, effective as of October 22, 2024 (incorporated by reference to Exhibit 3.1 to Registrant’s Current Report on Form 8-K, filed on October 22, 2024). |
| 3.2 | Certificate of Amendment to the Restated Certificate of Incorporation of the Company, effective as of October 23, 2024 (incorporated by reference to Exhibit 3.2 to Registrant’s Current Report on Form 8-K, filed on October 22, 2024). |
| 3.3 | Amended and Restated Bylaws, dated as of June 11, 2024 (incorporated by reference to Exhibit 3.3 to Registrant’s Current Report on Form 8-K, filed on October 22, 2024). |
| 10.1**+ | Employment Agreement, dated as of October 22, 2024, by and between the Company and Dr. Benjamin Yerxa. |
| 10.2**+ | Consulting Agreement, dated as of October 22, 2024, by and between the Company and Dr. Jean Bennett. |
| 10.3**+ | Second Amendment to 2021 Inducement Plan |
| 31.1 | Certification of Principal Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 31.2 | Certification of Principal Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. |
| 32.1* | Certification of Principal Executive Officer and Principal Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. |
| 101.INS | Inline XBRL Instance Document. |
| 101.SCH | Inline XBRL Taxonomy Extension Schema Document. |
| 101.CAL | Inline XBRL Taxonomy Extension Calculation Linkbase Document. |
| 101.DEF | Inline XBRL Taxonomy Extension Definition Linkbase Document. |
| 101.LAB | Inline XBRL Taxonomy Extension Label Linkbase Document. |
| 101.PRE | Inline XBRL Taxonomy Extension Presentation Linkbase Document. |
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) |
| * | Documents are furnished not filed. |
|---|
| ** | Indicates exhibits that are being filed herewith. |
|---|
| + | Indicates management contract or compensatory plan. |
|---|
Index
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.